157 related articles for article (PubMed ID: 7492105)
41. Recurrent group A streptococcal tonsillopharyngitis.
Pichichero ME; Green JL; Francis AB; Marsocci SM; Murphy AM; Hoeger W; Noriega C; Sorrento A; Gootnick J
Pediatr Infect Dis J; 1998 Sep; 17(9):809-15. PubMed ID: 9779767
[TBL] [Abstract][Full Text] [Related]
42. Incidence of streptococcal carriers in private pediatric practice.
Pichichero ME; Marsocci SM; Murphy ML; Hoeger W; Green JL; Sorrento A
Arch Pediatr Adolesc Med; 1999 Jun; 153(6):624-8. PubMed ID: 10357305
[TBL] [Abstract][Full Text] [Related]
43. A double-blind, multicenter comparative study of two regimens of clindamycin hydrochloride in the treatment of patients with acute streptococcal tonsillitis/pharyngitis.
Gallegos B; Rios A; Espidel A; Reynal JL
Clin Ther; 1995; 17(4):613-21. PubMed ID: 8565025
[TBL] [Abstract][Full Text] [Related]
44. Open-Label, parallel-group, multicenter, randomized study of cefprozil versus erythromycin in children with group A streptococcal pharyngitis/tonsillitis.
Brook I; Aronovitz GH; Pichichero ME
Clin Ther; 2001 Nov; 23(11):1889-900. PubMed ID: 11768840
[TBL] [Abstract][Full Text] [Related]
45. Short course therapy with cefuroxime axetil for group A streptococcal tonsillopharyngitis in children.
Mehra S; van Moerkerke M; Welck J; Sverrisson G; Sirotiakova J; Marr C; Staley H
Pediatr Infect Dis J; 1998 Jun; 17(6):452-7. PubMed ID: 9655533
[TBL] [Abstract][Full Text] [Related]
46. In-vivo protection of group A beta-haemolytic streptococci from penicillin by beta-lactamase-producing Bacteroides species.
Brook I; Pazzaglia G; Coolbaugh JC; Walker RI
J Antimicrob Chemother; 1983 Dec; 12(6):599-606. PubMed ID: 6363381
[TBL] [Abstract][Full Text] [Related]
47. The role of beta-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection.
Brook I
Rev Infect Dis; 1984; 6(5):601-7. PubMed ID: 6390637
[TBL] [Abstract][Full Text] [Related]
48. Comparison of clarithromycin and penicillin VK suspensions in the treatment of children with streptococcal pharyngitis and review of currently available alternative antibiotic therapies.
Still JG; Hubbard WC; Poole JM; Sheaffer CI; Chartrand S; Jacobs R
Pediatr Infect Dis J; 1993 Dec; 12(12 Suppl 3):S134-41. PubMed ID: 8295815
[TBL] [Abstract][Full Text] [Related]
49. Frequency of symptomatic relapses of group A beta-hemolytic streptococcal tonsillopharyngitis in children from 4 pediatric practices following penicillin, amoxicillin, and cephalosporin antibiotic treatment.
Casey JR; Kahn R; Gmoser D; Atlas E; Urbani K; Luber S; Pellman H; Pichichero ME
Clin Pediatr (Phila); 2008 Jul; 47(6):549-54. PubMed ID: 18490665
[TBL] [Abstract][Full Text] [Related]
50. [Susceptibility of Streptococcus pyogenes isolates from pharyngeal exudates in Cordoba (Spain)].
Gordillo RM; Lacasa MJ; Ibarra A; Rodríguez F; Casal M
Rev Esp Quimioter; 2003 Mar; 16(1):58-60. PubMed ID: 12750758
[TBL] [Abstract][Full Text] [Related]
51. Identification of clinical criteria for group A-beta hemolytic streptococcal pharyngitis in children living in a rheumatic fever endemic area.
Bassili A; Barakat S; Sawaf GE; Zaher S; Zaki A; Din Saleh EE
J Trop Pediatr; 2002 Oct; 48(5):285-93. PubMed ID: 12405171
[TBL] [Abstract][Full Text] [Related]
52. Efficacy of antibiotic prophylaxis for intrafamilial transmission of group A beta-hemolytic streptococci.
Kikuta H; Shibata M; Nakata S; Yamanaka T; Sakata H; Fujita K; Kobayashi K
Pediatr Infect Dis J; 2007 Feb; 26(2):139-41. PubMed ID: 17259876
[TBL] [Abstract][Full Text] [Related]
53. Five versus ten days treatment of streptococcal pharyngotonsillitis: a randomized controlled trial comparing cefpodoxime proxetil and phenoxymethyl penicillin.
Portier H; Chavanet P; Waldner-Combernoux A; Kisterman JP; Grey PC; Ichou F; Safran C
Scand J Infect Dis; 1994; 26(1):59-66. PubMed ID: 8191242
[TBL] [Abstract][Full Text] [Related]
54. Loracarbef versus penicillin V in the treatment of streptococcal pharyngitis and tonsillitis.
Müller O; Spirer Z; Wettich K
Infection; 1992; 20(5):301-8. PubMed ID: 1428189
[TBL] [Abstract][Full Text] [Related]
55. Clindamycin in recurrent group A streptococcal pharyngotonsillitis. An alternative to tonsillectomy?
Stjernquist-Desatnik A; Orrling A; Schalén C; Kamme C
Adv Exp Med Biol; 1997; 418():435-7. PubMed ID: 9331687
[No Abstract] [Full Text] [Related]
56. Streptococcal-A tonsillopharyngitis: a 5-day course of cefuroxime axetil versus a 10-day course of penicillin V. results depending on the children's age.
Scholz H
Chemotherapy; 2004 Apr; 50(1):51-4. PubMed ID: 15084807
[TBL] [Abstract][Full Text] [Related]
57. Association of penicillin tolerance with failure to eradicate group A streptococci from patients with pharyngitis.
Kim KS; Kaplan EL
J Pediatr; 1985 Nov; 107(5):681-4. PubMed ID: 3903089
[TBL] [Abstract][Full Text] [Related]
58. Therapy for pharyngitis and tonsillitis caused by group A beta-hemolytic streptococci: a meta-analysis comparing the efficacy and safety of cefadroxil monohydrate versus oral penicillin V.
Deeter RG; Kalman DL; Rogan MP; Chow SC
Clin Ther; 1992; 14(5):740-54. PubMed ID: 1468091
[TBL] [Abstract][Full Text] [Related]
59. Lack of influence of beta-lactamase-producing flora on recovery of group A streptococci after treatment of acute pharyngitis.
Tanz RR; Shulman ST; Sroka PA; Marubio S; Brook I; Yogev R
J Pediatr; 1990 Dec; 117(6):859-63. PubMed ID: 2123240
[TBL] [Abstract][Full Text] [Related]
60. Comparison of 5 days of extended-release clarithromycin versus 10 days of penicillin V for the treatment of streptococcal pharyngitis/tonsillitis: results of a multicenter, double-blind, randomized study in adolescent and adult patients.
Takker U; Dzyublyk O; Busman T; Notario G
Curr Med Res Opin; 2003; 19(5):421-9. PubMed ID: 13678479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
